SCHEMBL8869152

SCHEMBL8869152

CCCCNC(=O)c1ccc(S(=O)(=O)NC(=O)c2ccc(C(=O)NCC(=O)OC(C)C)nc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 1/20 0.54
P4HTM Q9NXG6 5/20 0.46
CYP2C9 P11712 3/20 0.41
CYP2C19 P33261 1/20 0.41
EGFR P00533 3/20 0.41
CA2 P00918 1/20 0.41
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
ALB P02768 1/20 0.40
TSHR P16473 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
FLT1 P17948 1/20 0.37
FLT4 P35916 1/20 0.37
KDR P35968 1/20 0.37
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MMP1 P03956 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8870235 0.96 EGLN1 (0.50) EGLN1P4HTMCYP2C9CYP2C19EGFR
SCHEMBL8868080 0.91 EGLN1 (0.47) EGLN1P4HTMEGFRALDH1A1LMNA
SCHEMBL8867730 0.91 P4HTM (0.48) EGLN1P4HTMEGFRFLT1FLT4
SCHEMBL8868634 0.91 P4HTM (0.51) EGLN1P4HTMCYP2C9EGFRCA2
SCHEMBL9139559 0.91 P4HTM (0.50) EGLN1P4HTMCYP2C9CYP2C19EGFR
SCHEMBL8868721 0.90 P4HTM (0.48) EGLN1P4HTMEGFRFLT1FLT4
SCHEMBL8869146 0.89 P4HTM (0.44) EGLN1P4HTMEGFRCA2ALDH1A1
SCHEMBL8868007 0.89 P4HTM (0.47) EGLN1P4HTMCYP2C9EGFRCA2
SCHEMBL8869206 0.89 P4HTM (0.47) EGLN1P4HTMNPC1RAB9A
SCHEMBL8869147 0.88 P4HTM (0.46) EGLN1P4HTMCYP2C9EGFRCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed